ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+50.9%
5Y CAGR+38.1%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
+50.9%/yr
vs +8.4%/yr prior
5Y CAGR
+38.1%/yr
Recent acceleration
Acceleration
+42.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
5x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $610.19M | +67.6% |
| 2024 | $364.17M | +19.3% |
| 2023 | $305.30M | +71.9% |
| 2022 | $177.60M | +53.7% |
| 2021 | $115.53M | -4.8% |
| 2020 | $121.32M | -15.4% |
| 2019 | $143.39M | +11.5% |
| 2018 | $128.55M | +31.4% |
| 2017 | $97.81M | +22.5% |
| 2016 | $79.84M | - |